Chemoradiation Combined With Panitumumab Followed by Surgery for Patients With Operable Esophageal Cancer.

Trial Profile

Chemoradiation Combined With Panitumumab Followed by Surgery for Patients With Operable Esophageal Cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 23 Mar 2013

At a glance

  • Drugs Panitumumab (Primary) ; Carboplatin; Paclitaxel
  • Indications Gastric cancer; Oesophageal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Mar 2013 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
    • 06 Mar 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top